Aug 10 (Reuters) - Zomedica Pharmaceuticals Corp
* Zomedica Pharmaceuticals Corp announces second quarter 2017 financial results
* Zomedica Pharmaceuticals Corp qtrly loss per share $0.02
* Zomedica Pharmaceuticals Corp - expects research and development expenditures in 2017 to be significantly higher than in 2016 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.